Exicure Inc (NASDAQ:XCUR) does about 1.50M shares in volume on a normal day but saw 4298090 shares change hands in the recent trading day. The company now has a market cap of 67.58M USD. Its current market price is $18.38, marking an increase of 69.24% compared to the previous close of $10.86. The 52 week high reached by this stock is $14.80 whilst the lowest price level in 52 weeks is $1.44. The script in recent trading has seen the stock touch a high of $12 and a low of $12.
Exicure Inc (XCUR) has a 20-day trading average at $4.64 and the current price is 24.19% off the 52-week high compared with 1176.39% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.60 and its 200-day simple moving average is $2.71. If we look at the stock’s price movements over the week, volatility stands at 57.19%, which decreases to 25.56% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 92.09 to suggest the stock is overbought.
The consensus objective for the share price is $10.00, suggesting that the stock has a potential downside of -83.8% over the period. The median price target is -53.17% away from the current levels at $12.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 13, 2021 when Chardan Capital Markets downgraded the stock to “Neutral” and issued a price target of between $2.25 and $0.40. Guggenheim initiated its price target at $9.
The current price level is 296.21%, 410.33%, and 577.16% away from its SMA20, SMA50, and SMA200 respectively, with the XCUR price moving below the 50-day SMA on current market day. Exicure Inc (XCUR) stock is up 533.79% over the week and 688.84% over the past month. Its price is 533.47% year-to-date and 635.20% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/30/2022, with the company’s earnings per share (EPS) of -40.5 below consensus estimates by -18. The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
Its 12-month price target is $12. To reach the target analysts have set, the stock logically needs to shrink -83.8 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $12, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $12.
Outstanding shares total 1.73M with insiders holding 46.78% of the shares and institutional holders owning 4.29% of the company’s common stock. The company has a return on investment of -57.44% and return on equity of -132.62%. The beta has a value of 1.73. Price to book ratio is 25.84 and price to sales ratio is 135.16.
